Jagaty Suman K, Behera Debasis, Gupta Saurabh, Subhankar Saswat, Rao Chinnari M, Jeeshitha Maram R
Department of Respiratory Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Department of Critical Care Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
J Family Med Prim Care. 2022 Jul;11(7):4083-4087. doi: 10.4103/jfmpc.jfmpc_2431_21. Epub 2022 Jul 22.
Bronchopleural fistula (BPF) is an uncommon entity in patients with coronavirus disease 2019 (COVID-19). It may arise due to various causes ranging from the disease itself to complications of treatment. If left untreated, it may increase the morbidity, hospital stay, and adversely affect the outcome. We hereby present a series of cases with a persistent pneumothorax and associated BPF due to varying etiologies. While three of our cases developed a pneumothorax while on non-invasive ventilation, other three were on oxygen therapy. One patient developed a spontaneous pyopneumothorax and septicemia and succumbed to the complications. Another patient on non-invasive ventilation died due to complications of pregnancy. The management of each case varied depending on their clinical presentation.
支气管胸膜瘘(BPF)在2019冠状病毒病(COVID-19)患者中并不常见。它可能由多种原因引起,从疾病本身到治疗并发症。如果不治疗,可能会增加发病率、延长住院时间,并对预后产生不利影响。我们在此介绍一系列因不同病因导致持续性气胸和相关BPF的病例。我们的病例中有3例在无创通气时发生气胸,另外3例接受氧疗。1例患者发生自发性脓气胸和败血症,死于并发症。另1例无创通气的患者死于妊娠并发症。每个病例的治疗方法因其临床表现而异。